CN103040900B - Medicine for treating bedsores - Google Patents
Medicine for treating bedsores Download PDFInfo
- Publication number
- CN103040900B CN103040900B CN201310002054.7A CN201310002054A CN103040900B CN 103040900 B CN103040900 B CN 103040900B CN 201310002054 A CN201310002054 A CN 201310002054A CN 103040900 B CN103040900 B CN 103040900B
- Authority
- CN
- China
- Prior art keywords
- grams
- parts
- medicine
- treating
- bedsores
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention belongs to the technical field of medicines, and particularly relates to a medicine for treating bedsores. The medicine for treating the bedsores is definite in curative effect and low in cost. The medicine is prepared by the following raw materials in parts by weight: 10-15 parts of calomelas, 10-15 parts of cinnabar, 30-40 parts of mountain tallow, 10-15 parts of realgar, 10-15 parts of frankincense, 5-7 parts of myrrh, 10-15 parts of white wax, 10-15 parts of fossil fragments and 30-40 parts of calaminae. An appropriate amount of the medicines are smashed respectively and serve as raw materials; the front nine raw materials are mixed and stirred evenly; and then vaseline 250 is compounded, mixed and stirred evenly. The medicine is used for treating the bedsores caused by various acute and chronic diseases, and has a better therapeutical effect.
Description
Technical field
The present invention relates to medical technical field, particularly a kind of medicine for the treatment of decubital ulcer.
Background technology
Decubital ulcer is because long-term bed local compression, blockage of main and collateral channels, stagnation of QI-blood, failure of skin and muscle to be nourished form down to tissue necrosis, decomposed.Due to skin ulcer face fat water seepage flow, wasting QI-blood, therefore generally belong to deficient syndrome, sends out but also easily contaminate to lift after decomposed, occurs scorchingly hot symptom.
Summary of the invention
The object of the invention is to provide a kind of determined curative effect, treatment decubital ulcer medicine with low cost.
The present invention to achieve these goals, be achieved through the following technical solutions: a kind of medicine for the treatment of decubital ulcer, it adopts the raw material of following weight parts to make: Calomelas 10-15, Cinnabaris 10-15, Halloysitum Rubrum 30-40, Realgar 10-15, Olibanum 10-15, Myrrha 5-7, white beeswax 10-15, Os Draconis 10-15, Calamina 30-40.
The medicine for the treatment of decubital ulcer of the present invention, adopts the raw material of following weight parts to make: 10 grams of Calomelass, 10 grams, Cinnabaris, 30 grams of Halloysitum Rubrums, 10 grams of Realgars, 10 grams of Olibanums, Myrrha 5,10 grams of white beeswax, 10 grams of Os Draconis, 30 grams of Calamina.
Preparation method: get above-mentioned various medicine appropriate, pulverize respectively, as raw material; According to above-mentioned formula, front nine taste raw materials are mixed and mixed well; 250 mixing of compatibility vaseline are mixed well again.
The Calamina of raw material of the present invention, the two astringent therapy of Halloysitum Rubrum, hemostasis, removing toxic substances improving acuity of vision and removing nebula, the antipruritic sore of removing dampness is monarch drug altogether; Os Draconis, Calomelas, Cinnabaris, Realgar: principal drug assistance is antibacterial, blood circulation promoting and blood stasis dispelling, antipruritic, granulation promoting, sore, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling are ministerial drug; Olibanum, white beeswax, Myrrha to be to improve the regulating qi and activating blood of this medicine, analgesic therapy, and loose blood blood stasis removing, subduing swelling and relieving pain, the merit that chases after malicious osmosis type and heat clearing away is adjuvant.Above-mentioned each taste medicine, Xiang Fuwei use, to reach the effect of heat clearing away removing dampness, blood circulation promoting and blood stasis dispelling.
The present invention cures mainly indication: for the decubital ulcer due to various acute and chronic diseases, infect, have good therapeutical effect.
When the present invention uses, first with light salt brine, clean bedsore wound, then by decubital ulcer plaster in affected part, the lighter changes dressings 1 every day, severe one one twice-daily, evening on daytime each once.
Calomelas: antifungic action, to trichophyton, permitted the dermatophytess such as blue achorion, Du's big belly microspore tinea bacterium difficult to understand, epidermophyton rubrum, star-shaped nocardia and all have inhibitory action in various degree. external parasite killing, counteracting toxic substances, sore; The removing food stagnancy that eliminates the phlegm for oral administration, the relieving constipation of relieving oedema or abdominal distension through diuresis or purgation.External treatment is for scabies, stubborn dermatitis, ecthyma, syphilis, skin infection, eczema; Take orally for sputum and stagnate, edema expands, difficulty in urination and defecation.
Cinnabaris: clear away heart-fire relieving convulsion, the removing toxic substances of calming the nerves.For palpitation and being susceptible to fright, insomnia and dreamful sleep, epilepsy is gone mad, infantile convulsion, blurring of vision, aphtha, sore throat, sore swollen toxin.
Halloysitum Rubrum: astringent therapy, hemostasis, external treatment skin infection is not held back, eczema and keratitis corneal ulcer.
Realgar: removing toxic substances parasite killing, removing dampness and eliminating phlegm, preventing the attack (or recurrence) of malaria.For carbuncle furuncle, snake bite and insect sting, abdominal pain due to worm stagnation, infantile convulsion, malaria.
Olibanum: regulating qi and activating blood, analgesic therapy, chases after poison.Control coagulation of QI-blood, trusted subordinate's pain, carbuncle pyogenic infections from tumour or sore, traumatic injury, dysmenorrhea, postnatal blood stasis twinge.
Myrrha: loose blood blood stasis removing, subduing swelling and relieving pain.Control traumatic injury, incised wound, muscles and bones, all pains of trusted subordinate, lump in the abdomen, amenorrhea, ulcer sore pain, anal fistula, diseases of the eye.
White beeswax: antibacterial, antiinflammatory, analgesia, eliminating phlegm and stopping cough, relievings asthma; There is hemostasis, granulation promoting, analgesic therapy.Control incised wound hemorrhage, hematuria, hematochezia, skin infection is burst and is not held back for a long time, primary sore.
Os Draconis: tranquillization with heavy prescription tranquillizing the mind by relieving convulsion, arresting sweating controlling nocturnal emission with astringent drugs, hemostasis astringing intestine to stop diarrhea, promoting tissue regeneration and ulcer healing.Control infantile convulsion demented, palpitation with a distress feeling is forgetful, insomnia and dreamful sleep, and spontaneous sweating, seminal emission stranguria with turbid discharge, tells nosebleed and has blood in stool, bleeding not during menses, dysentery proctoptosis, ulcer does not close up for a long time.
Calamina: removing toxic substances improving acuity of vision and removing nebula, the antipruritic sore of removing dampness.For conjunctival congestion and swelling pain, marginal blepharitis, nebula film bulbar conjunctiva polyp, ulcer being unable to heal, pus is dripping, eczema, skin pruritus.
Vaseline: medicinal ointment, lubrication, helps hemostasis.
Beneficial effect of the present invention: have draw out pus by applying a plaster to the affected part, except pus, anticorrosion, invigorate blood circulation, alleviating pain and detumescence is fast, and composite for born muscle antiphlogosis is fast, without transudate, do not infect, rapid infection control after using, clinical practice is evident in efficacy, and drug effect is unique, and the property of medicine is bringd into play, economical and practical, dosage is little, easy to use, convenient for production, storage convenience, suitable applying.
The specific embodiment
Embodiment 1
Treat a medicine for decubital ulcer, it adopts the raw material of following weight parts to make: 10 grams of Calomelass, 10 grams, Cinnabaris, 30 grams of Halloysitum Rubrums, 10 grams of Realgars, 10 grams of Olibanums, 5 grams of Myrrhas, 10 grams of white beeswax, 10 grams of Os Draconis, 30 grams of Calamina, 250 grams, vaseline.
Embodiment 2
Treat a medicine for decubital ulcer, adopt the raw material of following weight parts to make: 15 grams of Calomelass, 15 grams, Cinnabaris, 40 grams of Halloysitum Rubrums, 15 grams of Realgars, 15 grams of Olibanums, 6 grams of Myrrhas, 15 grams of white beeswax, 15 grams of Os Draconis, 40 grams of Calamina.
Embodiment 3
Treat a medicine for decubital ulcer, it adopts the raw material of following weight parts to make: 12 grams of Calomelass, 13 grams, Cinnabaris, 35 grams of Halloysitum Rubrums, 12 grams of Realgars, 12 grams of Olibanums, 7 grams of Myrrhas, 13 grams of white beeswax, 12 grams of Os Draconis, 35 grams of Calamina.
Embodiment 4
Treat a medicine for decubital ulcer, it adopts the raw material of following weight parts to make: 13 grams of Calomelass, 14 grams, Cinnabaris, 30 grams of Halloysitum Rubrums, 10 grams of Realgars, 13 grams of Olibanums, 7 grams of Myrrhas, 14 grams of white beeswax, 14 grams of Os Draconis, 38 grams of Calamina.
Preparation method:
Get above-mentioned various medicine appropriate, pulverize respectively, as raw material; Front nine taste raw materials in above-mentioned formula mix to be mixed well; 250 mixing of compatibility vaseline are mixed well again.
Summary of Clinical Research data:
1. clinical observation
(1) physical data
The inventor carries out clinical observation treatment to 69 routine patients in nearly ten years, and wherein, because cerebrovascular bed produces decubital ulcer 23 examples, old multiple chronic disease long-term bed produces decubital ulcer 33 examples, unexpected boiling hot, burn 13 examples.Male's 35 examples wherein, women's 34 examples, the age is between 25-78 years old.
(2) efficacy assessment standard: " healing ": clinical symptoms sign disappears, it is normal that functional activity recovers." effective ": the basic or large portion of clinical symptoms sign disappears." effectively ": clinical symptoms is clearly better or takes a turn for the better." invalid ": clinical symptoms sign is without improvement.
(4) therapeutic effect: clinical cure 66 examples, account for 95.7%; Effective 2 examples, account for 2.9%; Effective 1 example, accounts for 1.4%; Invalid 0 example, total effective rate 100%.
2. clinical verification is for example:
1) Wang Hailin, man, 78 years old, chronic disease long-term bed was suffered from decubital ulcer, used medicine of the present invention to change dressings for 1st and cured completely for twice, 7 day.
2) Liu Yuying, female, 65 years old, chronic disease long-term bed was suffered from decubital ulcer, used the medicine of the present invention recovery from illness in twice, 7 day of changing dressings for 1st.
3) Deng Chunyuan, female, 25 years old, chronic disease long-term bed was suffered from decubital ulcer, used the recovery from illness in twice, 5 day of changing dressings for 1st of this powder.
4) Ding Chunlian, female, 40 years old, chronic disease long-term bed was suffered from decubital ulcer, used the twice cooperation transfusion antiinflammatory of changing dressings for 1st of this powder, and recovery from illness in 6 days, does not stay cicatrix, and pore is unimpeded.
Claims (2)
1. a medicine for the treatment of decubital ulcer, is characterized in that: adopt the raw material of weight portion to be made for Calomelas 10-15, Cinnabaris 10-15, Halloysitum Rubrum 30-40, Realgar 10-15, Olibanum 10-15, Myrrha 5-7, white beeswax 10-15, Os Draconis 10-15, Calamina 30-40.
2. treat according to claim 1 the medicine of decubital ulcer, it is characterized in that: adopt the raw material of stating weight portion to make: 10 grams of Calomelass, 10 grams, Cinnabaris, 30 grams of Halloysitum Rubrums, 10 grams of Realgars, 10 grams of Olibanums, 5 grams of Myrrhas, 10 grams of white beeswax, 10 grams of Os Draconis, 30 grams of Calamina.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310002054.7A CN103040900B (en) | 2013-01-06 | 2013-01-06 | Medicine for treating bedsores |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310002054.7A CN103040900B (en) | 2013-01-06 | 2013-01-06 | Medicine for treating bedsores |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103040900A CN103040900A (en) | 2013-04-17 |
| CN103040900B true CN103040900B (en) | 2014-10-29 |
Family
ID=48053911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310002054.7A Expired - Fee Related CN103040900B (en) | 2013-01-06 | 2013-01-06 | Medicine for treating bedsores |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103040900B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893249A (en) * | 2014-04-23 | 2014-07-02 | 文成县刀锋科技有限公司 | Jinqiang medicine for treating sore suppuration |
| CN104547904A (en) * | 2014-12-26 | 2015-04-29 | 项阳 | Traditional Chinese medicine for treating bedsore |
| CN105435123A (en) * | 2015-12-30 | 2016-03-30 | 项阳 | Pharmaceutical composition for treating bedsore |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1101858A (en) * | 1994-03-02 | 1995-04-26 | 曾涛 | Powder medicine for removing necrotic tissue and promoting muscle growing |
| CN1548139A (en) * | 2003-05-19 | 2004-11-24 | 魏茂武 | Bedsore ointment and its prepn process |
| CN101780209A (en) * | 2010-02-26 | 2010-07-21 | 刘鑫 | Sore-curing ointment for treating pressure sore after paraplegia through external application |
| CN102366544A (en) * | 2011-08-20 | 2012-03-07 | 钱家美 | Bedsore ointment and preparation method thereof |
-
2013
- 2013-01-06 CN CN201310002054.7A patent/CN103040900B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1101858A (en) * | 1994-03-02 | 1995-04-26 | 曾涛 | Powder medicine for removing necrotic tissue and promoting muscle growing |
| CN1548139A (en) * | 2003-05-19 | 2004-11-24 | 魏茂武 | Bedsore ointment and its prepn process |
| CN101780209A (en) * | 2010-02-26 | 2010-07-21 | 刘鑫 | Sore-curing ointment for treating pressure sore after paraplegia through external application |
| CN102366544A (en) * | 2011-08-20 | 2012-03-07 | 钱家美 | Bedsore ointment and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103040900A (en) | 2013-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103071093B (en) | Medicine for treating gynecological diseases | |
| CN105214055A (en) | One treats neck-shoulder pain, lumbago and leg pain, arthritic Chinese medicine composition and preparation method | |
| CN103830478A (en) | Medicine for treatment of skin ulcer | |
| CN103860591A (en) | External-use Miao medicine used for regenerating tissues to heal wound after haemorrhoid fall-off and preparation method thereof | |
| CN102335309B (en) | Formula of ointment for treating burns and scalds | |
| CN103040900B (en) | Medicine for treating bedsores | |
| CN103845578B (en) | Treatment burn and scald, decubital ulcer, herpes zoster external-use tincture and preparation method | |
| CN104721406A (en) | Chinese medicinal composition for treating burns | |
| CN102784316B (en) | Cancer inhibition and flesh engendering medicine for treating burns, scalds, internal and external ulcer and cataract, and its preparation method | |
| CN102357165A (en) | Traditional Chinese medicine preparation for treating pressure sores | |
| CN102119975B (en) | Chinese herbal medicine ointment for treating ulcer, bedsore and vascular dermatoses | |
| CN104013818A (en) | Plaster for treating cancer pains | |
| CN101628063B (en) | Externally-applied plaster for treating synovitis | |
| CN102764360B (en) | Traditional Chinese medicine composition for treating acute cystitis | |
| CN104587206A (en) | Medicament for treating bedsore and preparation method of medicament | |
| CN102225104A (en) | Traditional Chinese and western medicine formula for treating hemorrhoid | |
| CN102846884A (en) | Analgesia plaster and preparation method thereof | |
| CN100355437C (en) | Medicine for treating scald and burn and preparing method | |
| CN104337913A (en) | External Chinese medicinal composition for treating pressure sore | |
| CN104623432A (en) | Traditional Chinese medicine composition for performing elimination treatment on tumor | |
| CN105477095A (en) | External traditional Chinese medicine ointment for recovery from burns and scalds | |
| CN103432518A (en) | External medicine composition for treating traumatic injuries and arthralgia syndrome and preparation method of external medicine composition | |
| CN108186864A (en) | A kind of Chinese medicine for treating acne | |
| CN103933389B (en) | Traditional Chinese medicine composition for treating ovarian cyst | |
| CN107126451A (en) | It is a kind of to treat external medicine composition of hemorrhoid and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141029 Termination date: 20170106 |